ID24527A - Proses pembuatan senyawa-senyawa farmasi - Google Patents
Proses pembuatan senyawa-senyawa farmasiInfo
- Publication number
- ID24527A ID24527A IDW990900D ID990900D ID24527A ID 24527 A ID24527 A ID 24527A ID W990900 D IDW990900 D ID W990900D ID 990900 D ID990900 D ID 990900D ID 24527 A ID24527 A ID 24527A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmaceutical compounds
- making pharmaceutical
- making
- compounds
- pharmaceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3911697P | 1997-02-26 | 1997-02-26 | |
| US3911497P | 1997-02-26 | 1997-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID24527A true ID24527A (id) | 2000-07-20 |
Family
ID=26715826
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW990901A ID22984A (id) | 1997-02-26 | 1998-02-25 | Proses epoksidasi selektif untuk pembuatan senyawa farmasi |
| IDW990900D ID24527A (id) | 1997-02-26 | 1998-02-25 | Proses pembuatan senyawa-senyawa farmasi |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW990901A ID22984A (id) | 1997-02-26 | 1998-02-25 | Proses epoksidasi selektif untuk pembuatan senyawa farmasi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6143909A (id) |
| EP (2) | EP0861838A3 (id) |
| JP (2) | JP2002513403A (id) |
| KR (2) | KR20000075671A (id) |
| CN (2) | CN1255121A (id) |
| AU (2) | AU738999B2 (id) |
| BR (2) | BR9807265A (id) |
| CA (2) | CA2281108A1 (id) |
| CZ (1) | CZ9902998A3 (id) |
| EA (2) | EA002547B1 (id) |
| ID (2) | ID22984A (id) |
| IL (2) | IL131205A0 (id) |
| NO (2) | NO994049D0 (id) |
| NZ (1) | NZ336918A (id) |
| PL (2) | PL335478A1 (id) |
| TR (2) | TR199902064T2 (id) |
| WO (2) | WO1998038158A1 (id) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0932601A4 (en) * | 1996-08-30 | 2000-02-02 | Lilly Co Eli | METHOD FOR PRODUCING PHARMACEUTICALS |
| AU4253997A (en) * | 1996-09-06 | 1998-03-26 | Eli Lilly And Company | Process and novel intermediates |
| JP2002527509A (ja) * | 1998-10-16 | 2002-08-27 | イーライ・リリー・アンド・カンパニー | 抗腫瘍剤を製造するための立体選択的な方法 |
| WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
| WO2000034253A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives |
| HK1049787B (en) | 1999-10-01 | 2014-07-25 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| US7229814B2 (en) * | 2004-05-05 | 2007-06-12 | Regents Of The University Of Minnesota | Nucleic acids and polypeptides involved in the production of cryptophycin |
| CN101962323B (zh) * | 2010-07-16 | 2013-06-05 | 中国人民解放军第二军医大学 | 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途 |
| CN111333560B (zh) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | 一种制备螺环β-内酰胺的方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
| US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
| US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
| US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
| WO1990009395A1 (en) * | 1989-02-17 | 1990-08-23 | Coselco Mimotopes Pty. Ltd. | Method for the use and synthesis of peptides |
| US5256802A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Process for the production of oxiranes |
| JPH08505604A (ja) * | 1992-11-06 | 1996-06-18 | カイロン ミモトープス プロプライエトリー リミテッド | モジュラーポリマーを合成するための支持体 |
| GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
| DE69427706T2 (de) * | 1993-12-21 | 2001-10-25 | University Of Hawaii, Honolulu | Cryptophycine |
| US5952298A (en) * | 1993-12-21 | 1999-09-14 | The University Of Hawaii | Cryptophycins |
| EP0785941B1 (en) * | 1994-10-14 | 2000-04-19 | Stratagene | Porphyrin labeling of polynucleotides |
| TJ347B (en) * | 1995-03-07 | 2002-10-06 | Univ Hawaii | Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia |
| CA2217051C (en) * | 1995-03-31 | 2006-05-30 | Nippon Chemiphar Co., Ltd. | Epoxysuccinic acid derivatives |
| US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| EP0850316A4 (en) * | 1995-08-30 | 2000-08-23 | Univ Hawaii | CRYPTOPHYCINE, OBTAINED FROM ABBERANTER BIOSYNTHESIS |
| ES2194129T3 (es) * | 1995-12-22 | 2003-11-16 | Univ Hawaii | Compuestos farmaceuticos. |
| AU724312B2 (en) * | 1996-02-07 | 2000-09-14 | Buckman Laboratories International, Inc. | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same |
| ES2156338T3 (es) * | 1996-02-27 | 2001-06-16 | Lilly Co Eli | Derivados de criptoficina y su uso como agentes antimicrotubulos. |
| JP2001502297A (ja) * | 1996-08-30 | 2001-02-20 | イーライ・リリー・アンド・カンパニー | 医薬用化合物 |
| DE69736067T9 (de) * | 1996-08-30 | 2007-10-31 | University Of Hawaii, Honolulu | Neue cryptophycin-derivate als antineoplastika |
| AU4169897A (en) * | 1996-08-30 | 1998-03-19 | Eli Lilly And Company | Pharmaceutical compounds |
| US6025506A (en) * | 1997-02-21 | 2000-02-15 | Dsm N.V. | Process for preparing an optically active phenylglycidyl acid derivative |
| TW438787B (en) * | 1997-02-27 | 2001-06-07 | Tanabe Seiyaku Co | Process for preparing optically active trans-3-substituted glycidic acid ester |
-
1998
- 1998-02-25 EA EA199900772A patent/EA002547B1/ru not_active IP Right Cessation
- 1998-02-25 KR KR1019997007737A patent/KR20000075671A/ko not_active Withdrawn
- 1998-02-25 PL PL98335478A patent/PL335478A1/xx unknown
- 1998-02-25 CZ CZ19992998A patent/CZ9902998A3/cs unknown
- 1998-02-25 JP JP53780398A patent/JP2002513403A/ja active Pending
- 1998-02-25 AU AU66672/98A patent/AU738999B2/en not_active Ceased
- 1998-02-25 EA EA199900770A patent/EA199900770A1/ru unknown
- 1998-02-25 KR KR1019997007686A patent/KR20000075623A/ko not_active Withdrawn
- 1998-02-25 CA CA002281108A patent/CA2281108A1/en not_active Abandoned
- 1998-02-25 IL IL13120598A patent/IL131205A0/xx unknown
- 1998-02-25 PL PL98335347A patent/PL335347A1/xx unknown
- 1998-02-25 AU AU66671/98A patent/AU6667198A/en not_active Abandoned
- 1998-02-25 US US09/380,005 patent/US6143909A/en not_active Expired - Fee Related
- 1998-02-25 ID IDW990901A patent/ID22984A/id unknown
- 1998-02-25 NZ NZ336918A patent/NZ336918A/en unknown
- 1998-02-25 CN CN98804251A patent/CN1255121A/zh active Pending
- 1998-02-25 IL IL13116298A patent/IL131162A0/xx unknown
- 1998-02-25 BR BR9807265-0A patent/BR9807265A/pt unknown
- 1998-02-25 TR TR1999/02064T patent/TR199902064T2/xx unknown
- 1998-02-25 JP JP53779998A patent/JP2002512603A/ja active Pending
- 1998-02-25 CA CA002281104A patent/CA2281104A1/en not_active Abandoned
- 1998-02-25 EP EP98301367A patent/EP0861838A3/en not_active Withdrawn
- 1998-02-25 EP EP98301368A patent/EP0861839A1/en not_active Ceased
- 1998-02-25 CN CN98804250A patent/CN1252788A/zh active Pending
- 1998-02-25 BR BR9811252-0A patent/BR9811252A/pt not_active IP Right Cessation
- 1998-02-25 ID IDW990900D patent/ID24527A/id unknown
- 1998-02-25 WO PCT/US1998/003655 patent/WO1998038158A1/en not_active Ceased
- 1998-02-25 WO PCT/US1998/003667 patent/WO1998038164A1/en not_active Ceased
- 1998-02-25 TR TR1999/02065T patent/TR199902065T2/xx unknown
-
1999
- 1999-08-23 NO NO994049A patent/NO994049D0/no not_active Application Discontinuation
- 1999-08-24 NO NO994083A patent/NO994083L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID17271A (id) | Proses untuk pengubahan etilbenzena | |
| PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
| ID26102A (id) | Proses pembuatan senyawa-senyawa stilbena | |
| ID22641A (id) | Proses pembuatan e-kaprolaktam | |
| ID20274A (id) | Proses untuk memproduksi diamina | |
| ID25901A (id) | Proses pembuatan 4-aminometil-pirolidin-3-on terlindung | |
| ID20624A (id) | Proses pembuatan 2'-flouro-5-metil-betha-l-rabinofuranosiluridin | |
| ID24312A (id) | Proses pembuatan hasil cetakan | |
| ID22840A (id) | Proses untuk penyiapan komposisi aspal | |
| BR9607626A (pt) | Novos compostos farmacéuticos de naftila | |
| ID22222A (id) | Proses pembuatan tiazolidinadiona tersubstitusi | |
| ID24527A (id) | Proses pembuatan senyawa-senyawa farmasi | |
| ID22906A (id) | Proses untuk memurnikan siloksana | |
| ID21901A (id) | Proses pembuatan garam-garam hidroksilamonium | |
| ID16364A (id) | Proses pembuatan senyawa multidentat fosfit | |
| ID22430A (id) | Proses pembuatan senyawa-senyawa benzotiazolona | |
| NO20001777D0 (no) | Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer | |
| ID24327A (id) | Produksi senyawa-senyawa avermektin | |
| NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
| NO995388D0 (no) | Fremgangsmåte for fremstilling av formylfosfonsyre | |
| ID24927A (id) | Proses sintesis zat-antara kloropurin | |
| ID24733A (id) | Proses pembuatan paroksetin hidroklorida | |
| ID20846A (id) | Proses produksi senyawa hidrokarbon monoalkenilaromatik | |
| EE200000401A (et) | Farmatseutilise preparaadi valmistamismeetod | |
| ID26708A (id) | Proses pembuatan kaprolaktam |